Wells Fargo’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Wells Fargo’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,206	Closed	-$3K	–	8135
2021 Q4	$3K	Hold	8,206	–	–	﹤0.01%	6841
2021 Q3	$5K	Buy	+8,206	New	+$7.88K	﹤0.01%	6397

Other funds holding APGNW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo's APGNW Position: Q1 2022 in Review

Wells Fargo sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q1 2022, closing a stake of 8,206 shares — an estimated $3K sold.

Wells Fargo first reported a position in APGNW in Q3 2021 and held it in 2 quarters. The position peaked at $5K in Q3 2021. 12 funds tracked by Wall St. Rank hold APGNW as of Q1 2022.

Wells Fargo reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
Wells Fargo sold 8,206 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q1 2022, an estimated $3K.
Wells Fargo first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2021 and held it in 2 quarters.
Wells Fargo's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $5K in Q3 2021.
12 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q1 2022.

Based on Wells Fargo's 13F filing for Q1 2022, filed 16 May 2022.